UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study

Hepatology (Baltimore, Md.), 2018-01, Vol.67 (1), p.36-47

2018

Volltextzugriff (PDF)

Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphoma

International journal of cancer, 2016-12, Vol.139 (11), p.2519-2528

2016

Volltextzugriff (PDF)

A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature

Frontiers in endocrinology (Lausanne), 2020-11, Vol.11, p.594264

2020

Volltextzugriff (PDF)

Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm

Therapeutic Advances in Hematology, 2019-09, Vol.10, p.204062071987473-2040620719874733

2019

Volltextzugriff (PDF)

Topoisomerase II inhibitors in AML: past, present, and future

Expert opinion on pharmacotherapy, 2019-09, Vol.20 (13), p.1637-1644

2019

Volltextzugriff (PDF)

Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Current hematologic malignancy reports, 2019-12, Vol.14 (6), p.515-522

2019

Volltextzugriff (PDF)

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors

Current hematologic malignancy reports, 2019-10, Vol.14 (5), p.460-468

2019

Volltextzugriff (PDF)

Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm

Expert review of clinical pharmacology, 2019-10, Vol.12 (10), p.941-946

2019

Volltextzugriff (PDF)

Clinicopathologic characteristics and outcomes of transformed diffuse large B‐cell lymphoma in hepatitis C virus‐infected patients

International journal of cancer, 2018-03, Vol.142 (5), p.940-948

2018

Volltextzugriff (PDF)

Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000–2016): Uncommon, with improved survival but still deadly often

The Journal of infection, 2017-12, Vol.75 (6), p.572-580

2017

Volltextzugriff (PDF)

Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study

The American journal of gastroenterology, 2019-02, Vol.114 (2), p.250-257

2019

Volltextzugriff (PDF)

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Leukemia research, 2022-10, Vol.121, p.106928-106928, Article 106928

2022

Volltextzugriff (PDF)

Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer

Clinical genitourinary cancer, 2024-02, Vol.22 (1), p.e31-e37.e1

2024

Volltextzugriff (PDF)

Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers

Oral oncology, 2018-10, Vol.85, p.103-105

2018

Volltextzugriff (PDF)

Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma

Clinical genitourinary cancer, 2022-04, Vol.20 (2), p.176-182

2022

Volltextzugriff (PDF)

Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer

Cancer, 2018-03, Vol.124 (5), p.960-965

2018

Volltextzugriff (PDF)

Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy

Leukemia & lymphoma, 2017-02, Vol.58 (2), p.485-488

2017

Volltextzugriff (PDF)

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center

Journal of the National Comprehensive Cancer Network, 2016-09, Vol.14 (9), p.1185-1188

2016

Volltextzugriff (PDF)

Germline APC (I1307K) mutation and clinical outcomes in prostate cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.144-144

2022

Volltextzugriff (PDF)

Germline APC (I1307K) mutation and clinical outcomes in prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.139-139

2023

Volltextzugriff (PDF)

Concomitant use of direct‐acting antivirals and chemotherapy in hepatitis C virus‐infected patients with cancer

Alimentary pharmacology & therapeutics, 2016-12, Vol.44 (11-12), p.1235-1241

2016

Volltextzugriff (PDF)

Impact of chronic hepatitis c virus infection in patients with non-oropharyngeal cancers

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18027-e18027

2018

Volltextzugriff (PDF)

Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients: A case-control study of 84 patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7553-7553

2017

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study

Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphoma

A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature

Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm

Topoisomerase II inhibitors in AML: past, present, and future

Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors

Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm

Clinicopathologic characteristics and outcomes of transformed diffuse large B‐cell lymphoma in hepatitis C virus‐infected patients

Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000–2016): Uncommon, with improved survival but still deadly often

Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer

Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers

Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma

Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy

Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center

Germline APC (I1307K) mutation and clinical outcomes in prostate cancer

Germline APC (I1307K) mutation and clinical outcomes in prostate cancer

Concomitant use of direct‐acting antivirals and chemotherapy in hepatitis C virus‐infected patients with cancer

Impact of chronic hepatitis c virus infection in patients with non-oropharyngeal cancers

Long-term outcomes of pembrolizumab (pembro) in combination with gemcitabine (gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIUC): A multicenter phase 2 trial

Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients: A case-control study of 84 patients

Suchergebnisse filtern